Nordic Life Sciences Database

STOCKHOLM, Jan. 20, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announces that the phase II study of MIV-711 in patients with osteoarthritis has been published in the respected journal Annals of Internal Medicine (DOI: 10.7326/M19-0675). The title of the article... Read more ››

By: PR Newswire Association LLC. - 20 Jan 2020

Related companies: Medivir AB

Sanofi : Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx

By: GlobenewsWire - 20 Jan 2020

Sanofi : Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx

By: GlobenewsWire - 20 Jan 2020

Sanofi : Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx

By: GlobenewsWire - 20 Jan 2020

China-Based Ivy Capital Invests in Betagenon's Clinical Stage AMPK Activator Program

STOCKHOLM, Jan. 20, 2020 /PRNewswire/ -- Balticgruppen Bio, the Umea based Biotech company focused on development of AMPK activator compounds, operating under the trademark Betagenon, has closed a funding round with China based asset management firm Ivy Capital granting the company 3 MUSD of... Read more ››

By: PR Newswire Association LLC. - 20 Jan 2020

Related companies: Betagenon AB

Sanofi: information concerning the total number of voting rights and shares, December 2019

By: GlobenewsWire - 17 Jan 2020

Sanofi: information concerning the total number of voting rights and shares, December 2019

By: GlobenewsWire - 17 Jan 2020

Sanofi: information concerning the total number of voting rights and shares, December 2019

By: GlobenewsWire - 17 Jan 2020

Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer

By: GlobenewsWire - 17 Jan 2020

Related companies: Veloxis Pharmaceuticals A/S

Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes and established CVD

By: GlobenewsWire - 16 Jan 2020

Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes and established CVD

By: GlobenewsWire - 16 Jan 2020

Clinical Cancer Research Publishes Results Supporting DiviTum as a Technology for Early Evaluation of Metastatic Breast Cancer Treatment

STOCKHOLM, Jan. 16, 2020 /PRNewswire/ -- Biovica, active in cancer diagnostics, today announced that the scientific journal Clinical Cancer Research has published data from the TREnd study, demonstrating the benefits of using DiviTum(®) when evaluating palbociclib treatment outcome... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020

Related companies: Biovica International AB

Managers' transactions

By: GlobenewsWire - 16 Jan 2020

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Looking for companies outside of the Nordic countries?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.